(Q77295050)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194739%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Methadone maintenance. Does dose determine differences in outcome? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194739%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

T Blaney

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194739%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R J Craig

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194739%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194739%20AND%20SRC:MED&resulttype=core&format=json

Journal of Substance Abuse Treatment

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194739%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194739%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194739%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

221-228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194739%20AND%20SRC:MED&resulttype=core&format=json

Position statement on methadone maintenance treatment

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Low (40 mg) versus high (80 mg) dose methadone in a 180-day heroin detoxification program.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Methadone dose and heroin use during maintenance treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Strategies for increasing retention in methadone programs

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Ineffective use of psychoactive drugs. Methadone treatment is no exception

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Effectiveness of low-dose methadone maintenance for the treatment of inner city heroin addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Methadone maintenance treatment. A ten-year perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Variations in methadone treatment practices. Results from a national study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Client initiative, inertia, and demographics: more powerful than treatment interventions in methadone maintenance?

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Medical complications in methadone patients

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Methadyl acetate and methadone as maintenance treatments for heroin addicts. A veterans administration cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Methadone dose and urine morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Methadone dosages and therapeutic compliance during a methadone maintenance program

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Is the counselor an "active ingredient" in substance abuse rehabilitation? An examination of treatment success among four counselors

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Long-term Follow-up of Clients of High- and Low-Dose Methadone Programs

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Psychiatric comorbidity: prevalence in methadone maintenance treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Dose-response effects of methadone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

Methadone dose and treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2898%2900031-2

7 January 2021

10.1016/S0740-5472(98)00031-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10194739%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference